https://adisinsight.springer.com/trials/700392305?error=cookies_not_supported&code=8f512d3b-75e1-4af2-acde-1e808e414bf7
Phase 3, Randomized, Open-Label Study of Nogapendekin Alfa Inbakicept in Combination With Standard...
This Phase 3 study will enroll adults with untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable mutations to test whether